Results 11 to 20 of about 14,731 (198)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2023
Chun-Yen Yu,1,* Po-Hsun Huang,1,* Leo Leung-Chit Tsang,1 Hsien-Wen Hsu,1 Wei-Xiong Lim,1 Ching-Chun Weng,1 Tung-Liang Huang,1 Chien-Chin Hsu,2 Chao-Long Chen,3 Hsin-You Ou,1 Yu-Fan Cheng1 1Department of Diagnostic Radiology, Kaohsiung Chang Gung ...
Yu CY, Huang PH, Tsang LLC, Hsu HW, Lim WX, Weng CC, Huang TL, Hsu CC, Chen CL, Ou HY, Cheng YF   +10 more
doaj   +2 more sources

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model

EJNMMI Physics, 2022
Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to those produced from conventional PET-based dosimetry.
E. Courtney Henry, Matthew Strugari, George Mawko, Kimberly Brewer, David Liu, Andrew C. Gordon, Jeffrey N. Bryan, Charles Maitz, James J. Karnia, Robert Abraham, S. Cheenu Kappadath, Alasdair Syme   +11 more
doaj   +2 more sources

Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.

PLoS ONE, 2021
BackgroundRecently, the use of Yttrium-90 transarterial radioembolization in non-surgical hepatocellular carcinoma was suggested but the evidence supporting its use is unclear.MethodsWe searched Medline, Embase, Web of Science and Cochrane CENTRAL from ...
Simon Lemieux, Alex Buies, Alexis F Turgeon, Julie Hallet, Gaétan Daigle, François Côté, Steeve Provencher   +6 more
doaj   +2 more sources

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

Hepatology, 2021
Locoregional therapies, including yttrium‐90 radioembolization, play an important role in the treatment of unresectable HCC. The aim of the LEGACY (Local radioEmbolization using Glass Microspheres for the Assessment of Tumor Control with Y‐90) study was ...
R. Salem, G. Johnson, Edward Kim, A. Riaz, V. Bishay, E. Boucher, K. Fowers, R. Lewandowski, S. Padia   +8 more
semanticscholar   +1 more source

A phase 1/2a trial of yttrium-90 radioembolization in combination with durvalumab for locally advanced unresectable hepatocellular carcinoma.

Clinical Cancer Research, 2023
PURPOSE Synergistic effect of radiotherapy and immunotherapy for the treatment of hepatocellular carcinoma (HCC) has been reported. This phase 1/2a pilot trial evaluated preliminary efficacy and safety of combination of radioembolization with yttrium-90 ...
Y. Lee, J. Y. Nam, E. Cho, Jeong‐Hoon Lee, S. Yu, Hyo-Cheol Kim, J. Paeng, Jung‐Hwan Yoon, Y. Kim   +8 more
semanticscholar   +1 more source

For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes

Cancers, 2023
Simple Summary Transarterial radioembolization (TARE) of the liver with Yttrium-90 (Y-90) microspheres is a prominent approach used to treat hepatocellular carcinoma (HCC), the most common primary liver cancer and the third-leading cause of cancer ...
C. Taswell, M. Studenski, T. Pennix, Bryan Stover, M. Georgiou, S. Venkat, Patricia D Jones, J. Zikria, L. Thornton, R. Yechieli, P. Mohan, L. Portelance, B. Spieler   +12 more
semanticscholar   +1 more source

AAPM Medical Physics Practice Guideline 14.a: Yttrium‐90 microsphere radioembolization

Journal of Applied Clinical Medical Physics, 2023
Radioembolization using Yttrium‐90 (90Y) microspheres is widely used to treat primary and metastatic liver tumors. The present work provides minimum practice guidelines for establishing and supporting such a program. Medical physicists play a key role in
Nathan Busse, M. Al-Ghazi, Nadine Abi-Jaoudeh, Diane Alvarez, A. Ayan, E. Chen, Michael D. Chuong, W. Dezarn, S. Enger, Stephen A. Graves, Robert F. Hobbs, Mary Ellen Jafari, S. P. Kim, N. Maughan, Andrew M. Polemi, Jennifer Stickel   +15 more
semanticscholar   +1 more source

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study

Frontiers in Oncology, 2023
Objective To report the incidence of radiation pneumonitis after radioembolization. Methods In this retrospective study, from May 2009 to July 2021, 782 consecutive patients underwent radioembolization in two institutes.
Hyo-Choel Kim, G. Kim
semanticscholar   +1 more source

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

European Journal of Nuclear Medicine and Molecular Imaging, 2021
A multidisciplinary expert panel convened to formulate state-of-the-art recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 (90Y)-resin microspheres.
H. Levillain, O. Bagni, C. Deroose, A. Dieudonné, S. Gnesin, O. Großer, S. Kappadath, A. Kennedy, N. Kokabi, David M. Liu, D. Madoff, A. Mahvash, A. Martinez de la Cuesta, D. Ng, P. Paprottka, C. Pettinato, M. Rodríguez-Fraile, R. Salem, B. Sangro, L. Strigari, D. Sze, Berlinda J. de Wit van der veen, P. Flamen   +22 more
semanticscholar   +1 more source

First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance.

Brachytherapy, 2023
PURPOSE Herein, we study if high-dose-rate (HDR) yttrium-90 (90Y) brachytherapy could be utilized by medical physicists, radiation oncologists, and ophthalmic surgeons. METHODS AND MATERIALS Yttrium-90 (90Y) beta-emitting brachytherapy sources received
P. Finger, R. Stewart, M. Rivard, Raymond Beers, J. Kamen, Shyam Lama, K. Chin, Kyle T. Mohney, Toby S. Welles, W. Sauerwein, K. Rosenzweig   +10 more
semanticscholar   +1 more source